Loading clinical trials...
Loading clinical trials...
The primary objective is to evaluate the performance parameters of the proposed DLAD (Carebot AI CXR) in comparison to individual radiologists.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Carebot s.r.o.
NCT00033137 · Kidney Neoplasms, Kidney Cancer, and more
NCT07344714 · Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant, and more
NCT07186933 · Postoperative Pulmonary Atelectasis, Postoperative Pulmonary Complications, and more
NCT06686251 · Consolidation, Lung Injury, and more
NCT07322796 · Pulmonary Nodule, Solitary, Smoking Behaviors
Nemocnice Havířov, p. o.
Havířov
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions